Does epigenetic markers of HLA gene show association with coronary artery disease in Indian subjects?
Background DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant Cp...
Saved in:
| Published in | Molecular biology reports Vol. 51; no. 1; p. 173 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Dordrecht
Springer Netherlands
01.12.2024
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0301-4851 1573-4978 1573-4978 |
| DOI | 10.1007/s11033-023-08974-5 |
Cover
| Abstract | Background
DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD.
Methods
Blood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann–Whitney U; Kruskal–Wallis’ rank test and two-way ANOVA by MedCalc (v19.6).
Results
Methylation levels in HLA-DQA1 for cg10217052 was 78.5 (37–85) and 76.5 (24–84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00–39.00) and 10.5 (5.00–29.0); while in cg08269402 were 52 (16–65) and 42.5 (17–61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity.
Conclusion
The present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD. |
|---|---|
| AbstractList | DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD.BACKGROUNDDNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD.Blood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann-Whitney U; Kruskal-Wallis' rank test and two-way ANOVA by MedCalc (v19.6).METHODSBlood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann-Whitney U; Kruskal-Wallis' rank test and two-way ANOVA by MedCalc (v19.6).Methylation levels in HLA-DQA1 for cg10217052 was 78.5 (37-85) and 76.5 (24-84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00-39.00) and 10.5 (5.00-29.0); while in cg08269402 were 52 (16-65) and 42.5 (17-61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity.RESULTSMethylation levels in HLA-DQA1 for cg10217052 was 78.5 (37-85) and 76.5 (24-84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00-39.00) and 10.5 (5.00-29.0); while in cg08269402 were 52 (16-65) and 42.5 (17-61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity.The present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD.CONCLUSIONThe present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD. BackgroundDNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD.MethodsBlood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann–Whitney U; Kruskal–Wallis’ rank test and two-way ANOVA by MedCalc (v19.6).ResultsMethylation levels in HLA-DQA1 for cg10217052 was 78.5 (37–85) and 76.5 (24–84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00–39.00) and 10.5 (5.00–29.0); while in cg08269402 were 52 (16–65) and 42.5 (17–61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity.ConclusionThe present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD. BACKGROUND: DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD. METHODS: Blood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann–Whitney U; Kruskal–Wallis’ rank test and two-way ANOVA by MedCalc (v19.6). RESULTS: Methylation levels in HLA-DQA1 for cg10217052 was 78.5 (37–85) and 76.5 (24–84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00–39.00) and 10.5 (5.00–29.0); while in cg08269402 were 52 (16–65) and 42.5 (17–61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity. CONCLUSION: The present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD. Background DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD. Methods Blood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann–Whitney U; Kruskal–Wallis’ rank test and two-way ANOVA by MedCalc (v19.6). Results Methylation levels in HLA-DQA1 for cg10217052 was 78.5 (37–85) and 76.5 (24–84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00–39.00) and 10.5 (5.00–29.0); while in cg08269402 were 52 (16–65) and 42.5 (17–61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity. Conclusion The present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD. DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD. Blood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann-Whitney U; Kruskal-Wallis' rank test and two-way ANOVA by MedCalc (v19.6). Methylation levels in HLA-DQA1 for cg10217052 was 78.5 (37-85) and 76.5 (24-84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00-39.00) and 10.5 (5.00-29.0); while in cg08269402 were 52 (16-65) and 42.5 (17-61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity. The present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD. |
| ArticleNumber | 173 |
| Author | Pillai, Sudhir Ponde, Chandrashekhar K. Rajani, Rajesh M. Paradkar, Minal U. Banerjee, Shyamashree Ashavaid, Tester F. |
| Author_xml | – sequence: 1 givenname: Shyamashree surname: Banerjee fullname: Banerjee, Shyamashree organization: Research Laboratories, P.D Hinduja Hospital & Medical Research Centre – sequence: 2 givenname: Minal U. surname: Paradkar fullname: Paradkar, Minal U. organization: Research Laboratories, P.D Hinduja Hospital & Medical Research Centre, Department of Biochemistry, P.D Hinduja Hospital & Medical Research Centre – sequence: 3 givenname: Chandrashekhar K. surname: Ponde fullname: Ponde, Chandrashekhar K. organization: Department of Cardiology, P.D Hinduja Hospital & Medical Research Centre – sequence: 4 givenname: Rajesh M. surname: Rajani fullname: Rajani, Rajesh M. organization: Department of Cardiology, P.D Hinduja Hospital & Medical Research Centre – sequence: 5 givenname: Sudhir surname: Pillai fullname: Pillai, Sudhir organization: Department of Cardiology, P.D Hinduja Hospital & Medical Research Centre – sequence: 6 givenname: Tester F. surname: Ashavaid fullname: Ashavaid, Tester F. email: dr_tashavaid@hindujahospital.com, tashavaid@gmail.com organization: Research Laboratories, P.D Hinduja Hospital & Medical Research Centre, Department of Biochemistry, P.D Hinduja Hospital & Medical Research Centre |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38252175$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkU1vEzEQhi1URNPAH-CALHHhsuDPXfuEqkI_pEhc4Gx5vbOtQ2IHz66q_nucpIDUQzlYY42ed-x53zNyknICQt5y9pEz1n1CzpmUDRP1GNupRr8gC6472SjbmROyYJLxRhnNT8kZ4poxpninX5FTaYQW9bog8CUDUtjFW0gwxUC3vvyEgjSP9Hp1Tvdtinf5nnrEHKKfYk70Pk53NOSSky8P1JcJahkigkegMdGbNESfKM79GsKEn1-Tl6PfILx5rEvy4_Lr94vrZvXt6ubifNUExczUgDRj4H0YWzu0bT8KpfrW-rZlbdAGuOyF7rlnKljTW_AqSKk6pm0YVDcKIZfkw3HuruRfM-DkthEDbDY-QZ7RSa5lu3fB_BcVtvqjBat2Lsn7J-g6zyXVRQ5UnaaNrdS7R2rutzC4XYnVywf3x-sKiCMQSkYsMP5FOHP7QN0xUFcDdYdA3V5knohCnA4hTMXHzfNSeZRifSfdQvn37WdUvwEi4bMk |
| CitedBy_id | crossref_primary_10_1016_j_aca_2024_343540 |
| Cites_doi | 10.1038/nature05919 10.1161/CIRCRESAHA.111.261388 10.2217/epi.12.62 10.1093/nar/16.3.1215 10.1194/jlr.M048504 10.1016/S0140-6736(12)60312-2 10.3389/fphar.2022.815977 10.1016/j.atherosclerosis.2018.07.014 10.1016/j.humimm.2011.11.003 10.4161/15592294.2014.970060 10.1038/ng1544 10.1186/s12920-015-0085-1 10.1042/BST20200602 10.1016/j.atherosclerosis.2004.04.027 10.1016/j.gheart.2012.10.003 10.1093/jn/132.8.2329s 10.1007/s11033-018-4507-y 10.1038/onc.2011.354 10.1016/S0021-9150(97)00101-9 10.1016/j.xcrm.2022.100805 10.1186/1868-7083-6-14 10.1097/MOL.0000000000000059 10.1007/s10654-014-9984-2 10.2217/epi.10.32 10.1016/j.ygeno.2023.110565 10.1002/0471142727.mb0709s91.Bisulfite 10.1038/nature05913 10.1016/j.tcm.2017.12.012 10.1089/dna.2007.0694 10.4161/epi.27981 10.3389/fgene.2020.00171 10.1007/s11033-020-05723-w 10.1371/journal.pone.0009692 10.1371/journal.pone.0102265 10.1186/s13073-020-00778-7 10.1016/j.atherosclerosis.2021.03.043 10.1016/j.gene.2014.02.034 10.1016/j.humimm.2017.06.003 10.1161/CIRCRESAHA.116.310324 10.1186/s13148-017-0353-3 10.1136/heartasia 10.1016/j.arr.2009.03.004 10.3892/ijmm.2018.3453 10.1038/nrg3230 10.1083/jcb.201412052 10.1016/j.gene.2019.144107 10.1056/NEJM199901143400207 10.1161/CIRCULATIONAHA.118.039357 10.1136/annrheumdis-2014-206998 10.1016/j.mam.2012.08.001 10.1016/0002-9149(94)90918-0 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer Nature B.V. 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2024. The Author(s), under exclusive licence to Springer Nature B.V. Copyright Springer Nature B.V. Dec 2024 |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature B.V. 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2024. The Author(s), under exclusive licence to Springer Nature B.V. – notice: Copyright Springer Nature B.V. Dec 2024 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7TM 8FD FR3 K9. P64 RC3 7X8 7S9 L.6 |
| DOI | 10.1007/s11033-023-08974-5 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Nucleic Acids Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Technology Research Database Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE - Academic Genetics Abstracts AGRICOLA MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry Biology |
| EISSN | 1573-4978 |
| EndPage | 173 |
| ExternalDocumentID | 38252175 10_1007_s11033_023_08974_5 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: Indian Council of Medical Research grantid: ICMR 2017-2844 funderid: http://dx.doi.org/10.13039/501100001411 – fundername: Indian Council of Medical Research grantid: ICMR 2017-2844 |
| GroupedDBID | --- -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 123 1SB 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3SX 4.4 406 408 409 40E 53G 5QI 5RE 5VS 67N 67Z 6NX 78A 7X7 88E 88I 8AO 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHBH AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABRTQ ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACGOD ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSTC ACZOJ ADBBV ADHHG ADHIR ADHKG ADIMF ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFGCZ AFHIU AFKRA AFLOW AFOHR AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHMBA AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN AZQEC B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ7 GQ8 GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LK8 LLZTM M1P M2P M4Y M7P MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 PF0 PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TUC TUS U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK6 WK8 YLTOR Z45 ZMTXR ZOVNA ZXP ~A9 ~EX ~KM AAYXX CITATION PUEGO CGR CUY CVF ECM EIF NPM 7TK 7TM 8FD FR3 K9. P64 RC3 7X8 7S9 L.6 |
| ID | FETCH-LOGICAL-c408t-e38fc1bcf69d66bf244b69a6606c58e13b25b1a04c98b9ea4c3347059cd47f223 |
| IEDL.DBID | AGYKE |
| ISSN | 0301-4851 1573-4978 |
| IngestDate | Fri Aug 22 20:36:49 EDT 2025 Wed Oct 01 13:34:45 EDT 2025 Tue Oct 07 05:52:07 EDT 2025 Mon Jul 21 05:55:24 EDT 2025 Thu Apr 24 23:07:25 EDT 2025 Wed Oct 01 03:58:50 EDT 2025 Mon Jul 21 06:06:48 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | gene Pyrosequencing Epigenetics DNA methylation Epigenome-wide association study Human leucocyte antigen Coronary artery disease Human leucocyte antigen (HLA) gene |
| Language | English |
| License | 2024. The Author(s), under exclusive licence to Springer Nature B.V. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c408t-e38fc1bcf69d66bf244b69a6606c58e13b25b1a04c98b9ea4c3347059cd47f223 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| PMID | 38252175 |
| PQID | 2917418589 |
| PQPubID | 54080 |
| PageCount | 1 |
| ParticipantIDs | proquest_miscellaneous_3153600418 proquest_miscellaneous_2917552057 proquest_journals_2917418589 pubmed_primary_38252175 crossref_primary_10_1007_s11033_023_08974_5 crossref_citationtrail_10_1007_s11033_023_08974_5 springer_journals_10_1007_s11033_023_08974_5 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-12-01 |
| PublicationDateYYYYMMDD | 2024-12-01 |
| PublicationDate_xml | – month: 12 year: 2024 text: 2024-12-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Dordrecht |
| PublicationPlace_xml | – name: Dordrecht – name: Netherlands |
| PublicationSubtitle | An International Journal on Molecular and Cellular Biology |
| PublicationTitle | Molecular biology reports |
| PublicationTitleAbbrev | Mol Biol Rep |
| PublicationTitleAlternate | Mol Biol Rep |
| PublicationYear | 2024 |
| Publisher | Springer Netherlands Springer Nature B.V |
| Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V |
| References | A Stanley (8974_CR31) 2017; 9 Y Xiong (8974_CR38) 2017; 78 JC Wang (8974_CR41) 2012; 111 M Swanberg (8974_CR34) 2005; 37 AP Feinberg (8974_CR6) 2007; 447 B Liu (8974_CR10) 2012; 73 SA Miller (8974_CR23) 1988; 16 V Calvanese (8974_CR43) 2009; 8 HU Khan (8974_CR53) 2014; 26 C Miceli-Richard (8974_CR47) 2016; 75 A Bird (8974_CR5) 2007; 447 T Mikeska (8974_CR40) 2010; 2 Y Salameh (8974_CR44) 2020 PA Jones (8974_CR7) 2012; 13 P Lopez-Serra (8974_CR8) 2012; 31 ML Lévesque (8974_CR22) 2014 S-P Guay (8974_CR18) 2012; 4 Y Dai (8974_CR12) 2022 B Indumathi (8974_CR52) 2020; 47 RP Darst (8974_CR24) 2010 S Zaina (8974_CR11) 2014; 25 P Peng (8974_CR29) 2014; 9 S Ghose (8974_CR4) 2019; 721 SP Guay (8974_CR35) 2014; 9 AC Frazier-Wood (8974_CR28) 2014; 55 I Tabas (8974_CR45) 2015; 209 M Nakatochi (8974_CR15) 2017; 9 P Raggi (8974_CR33) 2018; 276 L Duan (8974_CR2) 2018; 28 T Muka (8974_CR26) 2015; 30 S Udali (8974_CR3) 2013; 34 CA Castellani (8974_CR46) 2020 C Limas (8974_CR37) 1994; 74 P Sharma (8974_CR19) 2008; 27 MH Forouzanfar (8974_CR1) 2012; 7 MP Valencia-Morales (8974_CR9) 2015; 8 M Kim (8974_CR32) 2010 SA Ross (8974_CR42) 2002; 132 L Jonasson (8974_CR39) 1997; 133 S Banerjee (8974_CR21) 2019; 46 GK Hansson (8974_CR36) 1986; 64 R Ross (8974_CR27) 1999; 340 J Kain (8974_CR48) 2022 A Yilmaz (8974_CR13) 2004; 176 BF Voight (8974_CR30) 2012; 380 Y Yamada (8974_CR16) 2018 R Methorst (8974_CR50) 2021; 325 G Agha (8974_CR51) 2019; 140 X Yuan (8974_CR49) 2023 S-P Guay (8974_CR25) 2014; 6 K Ley (8974_CR14) 2020; 48 J Li (8974_CR17) 2017; 120 P Sharma (8974_CR20) 2014; 541 |
| References_xml | – volume: 447 start-page: 433 issue: 7143 year: 2007 ident: 8974_CR6 publication-title: Nature doi: 10.1038/nature05919 – volume: 111 start-page: 245 issue: 2 year: 2012 ident: 8974_CR41 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.111.261388 – volume: 4 start-page: 623 issue: 6 year: 2012 ident: 8974_CR18 publication-title: Epigenomics doi: 10.2217/epi.12.62 – volume: 16 start-page: 1215 issue: 3 year: 1988 ident: 8974_CR23 publication-title: Nucleic Acids Res doi: 10.1093/nar/16.3.1215 – volume: 55 start-page: 1324 issue: 7 year: 2014 ident: 8974_CR28 publication-title: J Lipid Res doi: 10.1194/jlr.M048504 – volume: 380 start-page: 572 issue: 9841 year: 2012 ident: 8974_CR30 publication-title: The Lancet doi: 10.1016/S0140-6736(12)60312-2 – year: 2022 ident: 8974_CR12 publication-title: Front Pharmacol doi: 10.3389/fphar.2022.815977 – volume: 276 start-page: 98 year: 2018 ident: 8974_CR33 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2018.07.014 – volume: 73 start-page: 122 issue: 1 year: 2012 ident: 8974_CR10 publication-title: Hum Immunol doi: 10.1016/j.humimm.2011.11.003 – year: 2014 ident: 8974_CR22 publication-title: Epigenetics doi: 10.4161/15592294.2014.970060 – volume: 26 start-page: 466 issue: 4 year: 2014 ident: 8974_CR53 publication-title: J Ayub Med Coll – volume: 37 start-page: 486 issue: 5 year: 2005 ident: 8974_CR34 publication-title: Nat Genet doi: 10.1038/ng1544 – volume: 8 start-page: 7 issue: 1 year: 2015 ident: 8974_CR9 publication-title: BMC Med Genomics doi: 10.1186/s12920-015-0085-1 – volume: 48 start-page: 2273 issue: 5 year: 2020 ident: 8974_CR14 publication-title: Biochem Soc Trans doi: 10.1042/BST20200602 – volume: 176 start-page: 101 issue: 1 year: 2004 ident: 8974_CR13 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2004.04.027 – volume: 7 start-page: 331 issue: 4 year: 2012 ident: 8974_CR1 publication-title: Glob Heart doi: 10.1016/j.gheart.2012.10.003 – volume: 132 start-page: 2406 issue: 8 SUPPL. year: 2002 ident: 8974_CR42 publication-title: J Nutr doi: 10.1093/jn/132.8.2329s – volume: 46 start-page: 541 issue: 1 year: 2019 ident: 8974_CR21 publication-title: Mol Biol Rep doi: 10.1007/s11033-018-4507-y – volume: 64 start-page: 261 issue: 2 year: 1986 ident: 8974_CR36 publication-title: Clin Exp Immunol – volume: 31 start-page: 1609 issue: 13 year: 2012 ident: 8974_CR8 publication-title: Oncogene doi: 10.1038/onc.2011.354 – volume: 133 start-page: 111 year: 1997 ident: 8974_CR39 publication-title: Atherosclerosis doi: 10.1016/S0021-9150(97)00101-9 – year: 2022 ident: 8974_CR48 publication-title: Cell Rep Med doi: 10.1016/j.xcrm.2022.100805 – volume: 6 start-page: 14 year: 2014 ident: 8974_CR25 publication-title: Clin Epigenetics doi: 10.1186/1868-7083-6-14 – volume: 25 start-page: 148 issue: 2 year: 2014 ident: 8974_CR11 publication-title: Curr Opin Lipidol doi: 10.1097/MOL.0000000000000059 – volume: 30 start-page: 251 issue: 4 year: 2015 ident: 8974_CR26 publication-title: Eur J Epidemiol doi: 10.1007/s10654-014-9984-2 – volume: 2 start-page: 561 issue: 4 year: 2010 ident: 8974_CR40 publication-title: Epigenomics doi: 10.2217/epi.10.32 – year: 2023 ident: 8974_CR49 publication-title: Genomics doi: 10.1016/j.ygeno.2023.110565 – year: 2010 ident: 8974_CR24 publication-title: Curr Protoc Mol Biol doi: 10.1002/0471142727.mb0709s91.Bisulfite – volume: 447 start-page: 396 issue: 7143 year: 2007 ident: 8974_CR5 publication-title: Nature doi: 10.1038/nature05913 – volume: 28 start-page: 311 issue: 5 year: 2018 ident: 8974_CR2 publication-title: Trends Cardiovasc Med doi: 10.1016/j.tcm.2017.12.012 – volume: 27 start-page: 357 issue: 7 year: 2008 ident: 8974_CR19 publication-title: DNA Cell Biol doi: 10.1089/dna.2007.0694 – volume: 9 start-page: 718 issue: 5 year: 2014 ident: 8974_CR35 publication-title: Epigenetics doi: 10.4161/epi.27981 – year: 2020 ident: 8974_CR44 publication-title: Front Genet doi: 10.3389/fgene.2020.00171 – volume: 47 start-page: 6693 issue: 9 year: 2020 ident: 8974_CR52 publication-title: Mol Biol Rep doi: 10.1007/s11033-020-05723-w – year: 2010 ident: 8974_CR32 publication-title: PLoS ONE doi: 10.1371/journal.pone.0009692 – volume: 9 start-page: 8 issue: 8 year: 2014 ident: 8974_CR29 publication-title: PLoS ONE doi: 10.1371/journal.pone.0102265 – year: 2020 ident: 8974_CR46 publication-title: Genome Med doi: 10.1186/s13073-020-00778-7 – volume: 325 start-page: 30 year: 2021 ident: 8974_CR50 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2021.03.043 – volume: 541 start-page: 31 issue: 1 year: 2014 ident: 8974_CR20 publication-title: Gene doi: 10.1016/j.gene.2014.02.034 – volume: 78 start-page: 540 issue: 9 year: 2017 ident: 8974_CR38 publication-title: Hum Immunol doi: 10.1016/j.humimm.2017.06.003 – volume: 120 start-page: 1754 issue: 11 year: 2017 ident: 8974_CR17 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.116.310324 – volume: 9 start-page: 1 issue: 1 year: 2017 ident: 8974_CR15 publication-title: Clin Epigenet doi: 10.1186/s13148-017-0353-3 – volume: 9 start-page: 1 year: 2017 ident: 8974_CR31 publication-title: Heart Asia doi: 10.1136/heartasia – volume: 8 start-page: 268 issue: 4 year: 2009 ident: 8974_CR43 publication-title: Ageing Res Rev doi: 10.1016/j.arr.2009.03.004 – year: 2018 ident: 8974_CR16 publication-title: Int J Mol Med doi: 10.3892/ijmm.2018.3453 – volume: 13 start-page: 484 issue: 7 year: 2012 ident: 8974_CR7 publication-title: Nat Rev Genet doi: 10.1038/nrg3230 – volume: 209 start-page: 13 issue: 1 year: 2015 ident: 8974_CR45 publication-title: J Cell Biol doi: 10.1083/jcb.201412052 – volume: 721 start-page: 144107 issue: 201 year: 2019 ident: 8974_CR4 publication-title: Gene doi: 10.1016/j.gene.2019.144107 – volume: 340 start-page: 115 issue: 2 year: 1999 ident: 8974_CR27 publication-title: N Engl J Med doi: 10.1056/NEJM199901143400207 – volume: 140 start-page: 645 issue: 8 year: 2019 ident: 8974_CR51 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.039357 – volume: 75 start-page: 933 issue: 5 year: 2016 ident: 8974_CR47 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2014-206998 – volume: 34 start-page: 883 issue: 4 year: 2013 ident: 8974_CR3 publication-title: Mol Aspects Med doi: 10.1016/j.mam.2012.08.001 – volume: 74 start-page: 510 issue: 5 year: 1994 ident: 8974_CR37 publication-title: Am J Cardiol doi: 10.1016/0002-9149(94)90918-0 |
| SSID | ssj0004175 |
| Score | 2.3875525 |
| Snippet | Background
DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery... DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD).... BackgroundDNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery... BACKGROUND: DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 173 |
| SubjectTerms | Animal Anatomy Animal Biochemistry Biomedical and Life Sciences blood Cardiovascular disease Coronary artery disease Coronary Artery Disease - genetics Coronary vessels CpG islands DNA methylation DNA Methylation - genetics DNA microarrays DQA1 protein Drb1 protein Epigenesis, Genetic - genetics Epigenetics genes Heart diseases high-throughput nucleotide sequencing Histocompatibility antigen HLA Histology Humans Life Sciences lipid composition Lipids Male males microarray technology Morphology Original Article Vascular Diseases Vein & artery diseases |
| Title | Does epigenetic markers of HLA gene show association with coronary artery disease in Indian subjects? |
| URI | https://link.springer.com/article/10.1007/s11033-023-08974-5 https://www.ncbi.nlm.nih.gov/pubmed/38252175 https://www.proquest.com/docview/2917418589 https://www.proquest.com/docview/2917552057 https://www.proquest.com/docview/3153600418 |
| Volume | 51 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1573-4978 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004175 issn: 0301-4851 databaseCode: AFBBN dateStart: 19970301 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1573-4978 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004175 issn: 0301-4851 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1573-4978 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004175 issn: 0301-4851 databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dT9RAEJ_AESMviqh4CmRNfNMl7X7048lcEDjE-OQl-NTsZzRqS653Medf72w_rkGEhNd220xnZzu_3Zn5DcAbl1jp8tRRxbingllDNWeW6jRyPpO5t7ZJkP2cTGfi46W87IrC6j7bvQ9JNn_qodgtDn3H0MfQKEMUTOUmbDV8WyPYmpx9vTgZ6iHjhmA3oH0qEFJ0xTL_f8t1h3QDZd6IkDaO5_QxzHqR23yTH0fLhT4yf_5hc7zvN-3Aow6JkklrOk9gw5W78KDtTbnahYfHfSu4p-A-VK4m7iowd4aiR_IrJPXMa1J5Mv00IeEyqb9Vv4kaZpuEI15iAkOCmq9Ikzu6Il1AiHwvyXkZbJPUSx3Ogur3z2B2evLleEq7_gzUiChbUMczb2JtfJLbJNEekYJOcpXgnsjIzMVcM6ljFQmTZzp3ShjORYp4zliResQlz2FUVqV7AcSn-Ju1wgijPAK4XEtmIh8rBHvK8siPIe4nqTAdeXnoofGzGGiXgyoLVGXRqLKQY3i7fuaqpe64c_R-P_dFt4zrguFmNrD7ZPkYXq9vo_JDVEWVrlq2Y6RkiHtvH8PRryTBLrMx7LV2tRaJ4x4d94UowLveRgYBbpf35f2Gv4JthnCsTcTZh9FivnQHCKcW-rBbPYewOWOTv6fIFPg |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Li9RAEC50RdaL6PoaXbUFb9qQ9COPkwyry6yOe9qBvYV-oqDJMplB5t9blccEWVfwmnRCkap0fdVV9RXA25B5Hco8cCNk5Ep4x60Unts8CbHQZfS-K5A9zxYr9flSXw5NYe1Y7T6mJLudemp2S2nuGPoYnhSIgrm-DXeIwIoY81diPnVDph29LmF9rhBQDK0yf3_Hn-7oGsa8lh_t3M7pA7g_4EU27xX8EG6F-gju9hMkd0dweDIObHsE4WMTWhauiF-TWhPZTyq9WbesiWyxnDO6zNpvzS9mJp0wOohljngMzHrHugrPHRvSNux7zc5qsiDWbi2d2LQfHsPq9NPFyYIPUxS4U0mx4UEW0aXWxaz0WWYj-nOblSbDyMXpIqTSCm1TkyhXFrYMRjkpVY6oy3mVR0QPT-CgburwDFjMcTP0yilnIsKs0mrhkpgahGTGyyTOIB0_ZuUGinGadPGjmsiRSQEVKqDqFFDpGbzbP3PVE2z8c_XxqKNq-NnaSmDISRw8RTmDN_vb-PEp92Hq0Gz7NVoLRKc3r5G4-2dkP8UMnvb634skMZLG6A0FeD8axCTAzfI-_7_lr-FwcfF1WS3Pzr-8gHsCAVRfOnMMB5v1NrxEALSxrzp7_w0Zp_np |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB5BEZQLKoWWQFsWiRusau_DjxOKWqL0oYoDkXqz9qlWAjuKE6H8e2b9iItKkbjaa2u0M_Z8szPzDcBHl1jp8tRRxbingllDNWeW6jRyPpO5t7YpkL1KpjNxfi2v73TxN9XufUqy7WkILE3l8nhu_fHQ-BaHGWTob2iUISKm8jE8EYEoAS16xsZDZ2TcUO0G3E8Fgouubebv7_jTNd3Dm_dypY0LmuzAiw47knGr7JfwyJW78LSdJrnehe2TfnjbK3CnlauJmweuzdCmSH6GMpxFTSpPppdjEi6T-qb6RdSgHxIOZYkJnAZqsSZNteeadCkccluSszJYE6lXOpze1F9ew2zy9fvJlHYTFagRUbakjmfexNr4JLdJoj36dp3kKsEoxsjMxVwzqWMVCZNnOndKGM5FigjMWJF6RBJ7sFVWpXsDxKf4Y7TCCKM8Qq5cS2YiHyuEZ8ryyI8g7jezMB3deJh68aMYiJKDAgpUQNEooJAj-LR5Zt6Sbfxz9UGvo6L78OqCYfgZ-HiyfAQfNrdx80MeRJWuWrVrpGSIVB9ew9ETJMF-shHst_rfiMQxqsZIDgX43BvEIMDD8r79v-Xv4dm300lxeXZ18Q6eM8RSbRXNAWwtFyt3iFhoqY8ac_8NhNf-JQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Does+epigenetic+markers+of+HLA+gene+show+association+with+coronary+artery+disease+in+Indian+subjects%3F&rft.jtitle=Molecular+biology+reports&rft.au=Banerjee%2C+Shyamashree&rft.au=Paradkar%2C+Minal+U.&rft.au=Ponde%2C+Chandrashekhar+K.&rft.au=Rajani%2C+Rajesh+M.&rft.date=2024-12-01&rft.issn=0301-4851&rft.eissn=1573-4978&rft.volume=51&rft.issue=1&rft_id=info:doi/10.1007%2Fs11033-023-08974-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11033_023_08974_5 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-4851&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-4851&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-4851&client=summon |